Pages that link to "Q40919170"
Jump to navigation
Jump to search
The following pages link to Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages (Q40919170):
Displaying 8 items.
- Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens (Q34280628) (← links)
- Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. (Q36446085) (← links)
- CYP51: A major drug target in the cytochrome P450 superfamily (Q37273355) (← links)
- Chagas' disease: an update on immune mechanisms and therapeutic strategies (Q37310959) (← links)
- Modulation of autoimmunity by treatment of an infectious disease (Q42432412) (← links)
- TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi (Q43887802) (← links)
- Benznidazole modulates cell proliferation in acute leukemia cells. (Q45071683) (← links)
- Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection. (Q47093622) (← links)